Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
boston
3
×
boston blog main
boston top stories
life sciences
national blog main
deals
national top stories
san francisco blog main
san francisco top stories
ally bridge group
big data analytics
biontech
biotech
blackrock
boehringer ingelheim
casdin capital
clinical trials
crispr
curevac
david walt
diabetic nephropathy
diagnostics
eli lilly
eventide asset management
feng zhang
focal segmental glomerulosclerosis
gene editing
goldfinch bio
illumina
infectious diseases
irving investors
jay ghosh
jennifer doudna
jim collins
john shiver
mammoth biosciences
moderna therapeutics
mrna
new york blog main
new york top stories
What
bio
3
×
medicines
3
×
diseases
new
analysis
bets
biotech
bring
cancer
comes
companies
company
create
crispr
cut
date
deal
develop
diagnostic
drug
editing
effective
employing
enticed
evidence
fix
gene
genetic
goldfinch
hasn’t
heats
high
human
ipo
kidney
later
latest
launches
lead
messenger
Language
unset
Current search:
bio
×
photo
×
medicines
×
boston
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
6 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
